Sands Capital Alternatives, LLC Long-Term Concentrated

Location: Arlington, VA

CIK: 0001846444 · Show all filings

Period: Q3 2021 (Next →)

Filing Date: Nov 12, 2021

Total Value: $663M (100.0% shares, 0.0% debt)

Holdings (13)

PATH UIPATH INC 30.2%

Value $201M Shares 3,811,779 Est. Cost $60.53 Unrealized 0.0%

DASH DOORDASH INC 19.6%

Value $130M Shares 630,217 Est. Cost $191.28 Unrealized 0.0%

— DICE THERAPEUTICS, INC. 15.6%

Value $103M Shares 3,148,970 Est. Cost $32.75 Unrealized —

SNOW SNOWFLAKE INC 14.4%

Value $95.74M Shares 316,576 Est. Cost $284.41 Unrealized 0.0%

ABOS ACUMEN PHARMACEUTICALS, INC 7.7%

Value $50.78M Shares 3,417,075 Est. Cost $16.64 Unrealized 0.0%

— KARUNA THERAPEUTICS, INC. 4.9%

Value $32.77M Shares 267,895 Est. Cost $122.33 Unrealized —

TSHA TAYSHA GENE THERAPIES INC 2.0%

Value $13.5M Shares 724,873 Est. Cost $19.01 Unrealized 0.0%

MASS 908 DEVICES INC 1.6%

Value $10.62M Shares 326,427 Est. Cost $33.97 Unrealized 0.0%

CADL CANDEL THERAPEUTICS, INC 1.3%

Value $8.799M Shares 811,737 Est. Cost $8.29 Unrealized 0.0%

RGEN REPLIGEN CORP. 1.0%

Value $6.515M Shares 22,544 Est. Cost $256.54 Unrealized 0.0%

TARS TARSUS PHARMACEUTICALS INC 0.8%

Value $5.603M Shares 260,000 Est. Cost $24.75 Unrealized 0.0%

— SPRUCE BIOSCIENCES INC 0.7%

Value $4.73M Shares 787,007 Est. Cost $6.01 Unrealized —

ABSI ABSCI CORP. 0.1%

Value $672K Shares 57,804 Est. Cost $19.41 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
PATH	UIPATH INC	3,811,779	$201M	30.2%	$60.53	0.0%	COM CL A	90364P105
DASH	DOORDASH INC	630,217	$130M	19.6%	$191.28	0.0%	COM CL A	25809K105
—	DICE THERAPEUTICS, INC.	3,148,970	$103M	15.6%	$32.75	—	COM	23345J104
SNOW	SNOWFLAKE INC	316,576	$95.74M	14.4%	$284.41	0.0%	COM CL A	833445109
ABOS	ACUMEN PHARMACEUTICALS, INC	3,417,075	$50.78M	7.7%	$16.64	0.0%	COM	00509G209
—	KARUNA THERAPEUTICS, INC.	267,895	$32.77M	4.9%	$122.33	—	COM	48576A100
TSHA	TAYSHA GENE THERAPIES INC	724,873	$13.5M	2.0%	$19.01	0.0%	COM	877619106
MASS	908 DEVICES INC	326,427	$10.62M	1.6%	$33.97	0.0%	COM	65443P102
CADL	CANDEL THERAPEUTICS, INC	811,737	$8.799M	1.3%	$8.29	0.0%	COM	137404109
RGEN	REPLIGEN CORP.	22,544	$6.515M	1.0%	$256.54	0.0%	COM	759916109
TARS	TARSUS PHARMACEUTICALS INC	260,000	$5.603M	0.8%	$24.75	0.0%	COM	87650L103
—	SPRUCE BIOSCIENCES INC	787,007	$4.73M	0.7%	$6.01	—	COM	85209E109
ABSI	ABSCI CORP.	57,804	$672K	0.1%	$19.41	0.0%	COM	00091E109